Protalix Biotherapeutics, Inc. (PLX)

1.73 -0.07 (-3.89%) USD  |  NYAM  |  Dec 19, 16:00
1.745 +0.02 (+0.87%) After-Hours: 20:00
More

Protalix Biotherapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
PAVmed, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Electromed, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade